NASDAQ:KRRO | Free Cash Flow | Korro Bio, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2017-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$16.07M$21,000.00-$16.1M
2025-12-31-$17.7M$84,000.00-$17.79M
2025-03-31-$24.45M$119,000.00-$24.57M
2024-12-31-$7.5M$1.45M-$8.95M
2024-03-31-$21.89M$5.61M-$27.5M
2023-12-31-$21.11M$1.66M-$22.76M
2023-03-31-$19.69M$1.51M-$21.2M
2022-12-31-$11.03M$5.14M-$16.16M-261.28%
2022-03-31-$17.34M$12,000.00-$17.36M
2021-12-31-$17.89M$61,000.00-$17.95M
2021-03-31-$25.47M$543,000.00-$26.02M
2020-12-31-$14.83M$4.42M-$19.25M
2020-03-31-$9.36M$343,000.00-$9.71M
2019-12-31-$29.74M$421,000.00-$30.16M
2019-03-31-$6.15M$459,000.00-$6.61M
2018-12-31-$4.72M$239,000.00-$4.96M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$78.56M$518,000.00-$79.08M
2024-12-31-$60.07M$17.9M-$77.98M
2023-12-31-$67.28M$7.84M-$75.12M
2022-12-31-$53.65M$5.14M-$58.78M
2021-12-31-$76.06M$2.91M-$78.97M
2020-12-31-$45.19M$6.67M-$51.86M
2019-12-31$34.22M$1.06M$33.15M
2018-12-31-$17.02M$436,000.00-$17.46M
2017-12-31-$14.61M$1.86M-$16.48M